- Email: [email protected]
Codexis inks enzyme supply deal with Tate & Lyle
FOCUS electrochemistry and catalysis. In 2017, it aims to add more projects involving the biological route.
Original Source: Materials World, Jan 2017, 25 (1), (Website: http://www.iom3.org) © The Institute of Materials, Minerals and Mining (IOM3) 2017.
ON
C ATA LY S T S
'CodeEvolver' protein technology for use in Tate & Lyle's food ingredient production.
Original Source: Chemical Weekly, 10 Jan 2017, 183 (Website: http://www. chemicalweekly.com) © Sevak Publications & Chemical Weekly Database P Ltd 2017.
Evonik caps busy 2016 with two more moves
Novozymes expands India production capabilities
German specialty chemicals firm Evonik AG is substantially expanding its silica business in North America with a total investment of $750 M through two major moves. The company has inked a deal to buy J.M. Huber Corp's silica division for $630 M to boost Evonik's position in Asia and North America. Huber Silica has around 4000 employees in six facilities, two in Europe, two in the US, one in India, and one in China. The deal is slated for completion by 2H 2017, subject to the clearance from relevant authorities. In 2016, Huber Silica is projected to reach roughly $300 M in sales with $60 M EBITDA. By 2021, the deal is expected to provide nearly $20 M in cost synergies mainly in the field of logistics, production, and procurement in addition to the integration of the product portfolio. A Freedonia Group analyst predicts the US precipitated silica market to grow by nearly 5%/y through 2019. Evonik also announced that it will construct a precipitated silica facility at the Charleston International Manufacturing Center in Charleston, SC, US, with nearly $120 M investment. The plant is slated for completion in 2018, and will create 55 jobs. Evonik earlier announced that the plant would manufacture its Ultrasil-brand of rubber silica. The firm received a $500,000 Economic Development grant from the South Carolina Department of Commerce to fund the project. Evonik is also building a silica manufacturing plant in Brazil that is slated for completion by end-2017.
Novozymes has secured land in the Patalganga industrial area in India where it will build a new enzyme manufacturing and supply chain facilities that will commence operations in 2018. The company will initially spend around DKR 300 M (Rup 300 crore) on the facility, which will hire 150 staff during phase one. The new plant, which will serve the Indian and Southeast Asian markets, will manufacture enzymes via solid-state fermentation. It will also produce enzymes imported from the company's overseas sites. (1 crore=10 M, 1 lakh=100,000).
Original Source: Rubber and Plastics News, 9 Jan 2017, 46 (10), 4 (Website: http://www. rubbernews.com) © Crain Communications Inc 2017.
AkzoNobel signs JDA with Itaconix for bio-based polymers AkzoNobel has signed a framework joint development agreement with Itaconix to explore opportunities for the production of biobased polymers. With this agreement, AkzoNobel will pursue the development and commercialization of bio-based polymers. Itaconix will contribute a proprietary polymerization technology to turn itaconic acid (obtained from sugars through fermentation) into polymers.
Original Source: AkzoNobel, 2017. Found on SpecialChem Coatings and Inks Formulation, 30 Jan 2017, (Website: http://www. specialchem4coatings.com).
Codexis inks enzyme supply deal with Tate & Lyle Under an exclusive deal, Codexis will supply proprietary enzyme engineered using its
4
Original Source: Chemical Engineering World, Nov 2016, 51 (11), 12 (Website: http://www. cewindia.com) © Jasubhai Group 2016.
Novozymes release: company reports 6% organic sales growth in 4Q 2016 Novozymes, the world's largest producer of industrial enzymes, announced on 18 Jan 2017 its results for 2016. Sales grew by 2% organically and by 1% in DKR, primarily driven by Agriculture & Feed and Technical & Pharma. The EBIT margin improved by 0.2 percentage points to 27.9%, and EBIT grew by 2%. Net profit increased by 8%. In 4Q 2016, sales grew by 6% organically and by 8% in DKR compared with 4Q 2015. The proposed dividend payout of DKR 4.00/share is equivalent to dividend growth of 14% and a payout ratio of 39%. In 2017, Novozymes expects to deliver organic sales growth of 25%, with contributions from all five business areas. The company expects an EBIT margin of around 28% and a ROIC including goodwill of 24-25%. A new stock buyback programme worth up to DKR 2 bn is planned.
Original Source: BioSpace, 19 Jan 2017, (Website: http://www.biospace.com) © Biospace, 2017.
Business briefs: Novozymes has launched Fermax Fermax, an enzyme protease that inhibits foam growth during the sugarcane ethanol fermentation process, has been launched by Novozymes. Compared with using chemicals, testing partners reported an up to 20% cost reduction when utilizing the enzyme.
Original Source: Ethanol Producer Magazine, Jan 2017, 23 (1), 19 (Website: http://www. ethanolproducer.com/) © BBI International 2017.
Synthetic Genomics and ExxonMobil renew algae biofuels research agreement Synthetic Genomics Inc and ExxonMobil announced on 18 Jan 2017 that they have extended their agreement to conduct joint research into advanced algae biofuels after making significant progress in understanding algae genetics, growth characteristics and increasing oil production. ExxonMobil and Synthetic Genomics have been jointly researching and developing oil from algae for use as a renewable, lower-emission alternative to traditional transportation fuels since launching the programme in 2009. Work continues toward developing strains of algae that demonstrate significantly improved photosynthetic efficiency and oil production through selection and genetic engineering of higher-performance algae strains. The agreement continues to focus on Synthetic Genomics' core strengths in synthetic biology and builds on recent discoveries of biological pathways regulating lipid production and growth in advanced algal strains. The vice president for research and development at ExxonMobil Research and Engineering Company, said that renewal of the agreement underscores the importance of the research and recognition of milestones the team has achieved together over the past few years. The development of algae biofuels and a path toward commercial-scale production remain key components of ExxonMobil's suite of research projects focused on producing energy to meet global demand while reducing greenhouse gas emissions to mitigate the risk of climate change.
Original Source: ExxonMobil, 18 Jan 2017, (Website: http://www.exxonmobil.com/) © ExxonMobil Mobil Corporation 2017.
Avantium takes over Liquid Light; commercializing technology for cosmetics production Avantium has announced it has acquired the assets of Liquid Light Inc. Liquid Light has developed proprietary process technology to make major chemicals from low-cost, globallyabundant carbon dioxide (CO2). The acquisition combines the technologies of both Liquid Light and Avantium to develop a world leading electro-catalysis platform and to commercialize new process technologies using CO2 as feedstock to produce sustainable chemicals and materials. Its patent portfolio includes filings on producing multiple chemical building blocks used in large existing markets, including oxalic acid, glycolic acid, ethylene glycol, propylene, isopropanol, methylmethacrylate and acetic acid for the production of polymers, coatings and cosmetics. The technology and patent portfolio of Liquid Light will be integrated in Avantium's Renewable Chemistry business unit and its existing R&D program in electrochemistry. The combination of Liquid Light's expertise in electrochemistry with Avantium's expertise in catalysis and process engineering will be the basis of an unrivalled technology platform to develop novel production technologies for converting CO2 to chemicals and materials.
March 2017
Original Source: Materials World, Jan 2017, 25 (1), (Website: http://www.iom3.org) © The Institute of Materials, Minerals and Mining (IOM3) 2017.
ON
C ATA LY S T S
'CodeEvolver' protein technology for use in Tate & Lyle's food ingredient production.
Original Source: Chemical Weekly, 10 Jan 2017, 183 (Website: http://www. chemicalweekly.com) © Sevak Publications & Chemical Weekly Database P Ltd 2017.
Evonik caps busy 2016 with two more moves
Novozymes expands India production capabilities
German specialty chemicals firm Evonik AG is substantially expanding its silica business in North America with a total investment of $750 M through two major moves. The company has inked a deal to buy J.M. Huber Corp's silica division for $630 M to boost Evonik's position in Asia and North America. Huber Silica has around 4000 employees in six facilities, two in Europe, two in the US, one in India, and one in China. The deal is slated for completion by 2H 2017, subject to the clearance from relevant authorities. In 2016, Huber Silica is projected to reach roughly $300 M in sales with $60 M EBITDA. By 2021, the deal is expected to provide nearly $20 M in cost synergies mainly in the field of logistics, production, and procurement in addition to the integration of the product portfolio. A Freedonia Group analyst predicts the US precipitated silica market to grow by nearly 5%/y through 2019. Evonik also announced that it will construct a precipitated silica facility at the Charleston International Manufacturing Center in Charleston, SC, US, with nearly $120 M investment. The plant is slated for completion in 2018, and will create 55 jobs. Evonik earlier announced that the plant would manufacture its Ultrasil-brand of rubber silica. The firm received a $500,000 Economic Development grant from the South Carolina Department of Commerce to fund the project. Evonik is also building a silica manufacturing plant in Brazil that is slated for completion by end-2017.
Novozymes has secured land in the Patalganga industrial area in India where it will build a new enzyme manufacturing and supply chain facilities that will commence operations in 2018. The company will initially spend around DKR 300 M (Rup 300 crore) on the facility, which will hire 150 staff during phase one. The new plant, which will serve the Indian and Southeast Asian markets, will manufacture enzymes via solid-state fermentation. It will also produce enzymes imported from the company's overseas sites. (1 crore=10 M, 1 lakh=100,000).
Original Source: Rubber and Plastics News, 9 Jan 2017, 46 (10), 4 (Website: http://www. rubbernews.com) © Crain Communications Inc 2017.
AkzoNobel signs JDA with Itaconix for bio-based polymers AkzoNobel has signed a framework joint development agreement with Itaconix to explore opportunities for the production of biobased polymers. With this agreement, AkzoNobel will pursue the development and commercialization of bio-based polymers. Itaconix will contribute a proprietary polymerization technology to turn itaconic acid (obtained from sugars through fermentation) into polymers.
Original Source: AkzoNobel, 2017. Found on SpecialChem Coatings and Inks Formulation, 30 Jan 2017, (Website: http://www. specialchem4coatings.com).
Codexis inks enzyme supply deal with Tate & Lyle Under an exclusive deal, Codexis will supply proprietary enzyme engineered using its
4
Original Source: Chemical Engineering World, Nov 2016, 51 (11), 12 (Website: http://www. cewindia.com) © Jasubhai Group 2016.
Novozymes release: company reports 6% organic sales growth in 4Q 2016 Novozymes, the world's largest producer of industrial enzymes, announced on 18 Jan 2017 its results for 2016. Sales grew by 2% organically and by 1% in DKR, primarily driven by Agriculture & Feed and Technical & Pharma. The EBIT margin improved by 0.2 percentage points to 27.9%, and EBIT grew by 2%. Net profit increased by 8%. In 4Q 2016, sales grew by 6% organically and by 8% in DKR compared with 4Q 2015. The proposed dividend payout of DKR 4.00/share is equivalent to dividend growth of 14% and a payout ratio of 39%. In 2017, Novozymes expects to deliver organic sales growth of 25%, with contributions from all five business areas. The company expects an EBIT margin of around 28% and a ROIC including goodwill of 24-25%. A new stock buyback programme worth up to DKR 2 bn is planned.
Original Source: BioSpace, 19 Jan 2017, (Website: http://www.biospace.com) © Biospace, 2017.
Business briefs: Novozymes has launched Fermax Fermax, an enzyme protease that inhibits foam growth during the sugarcane ethanol fermentation process, has been launched by Novozymes. Compared with using chemicals, testing partners reported an up to 20% cost reduction when utilizing the enzyme.
Original Source: Ethanol Producer Magazine, Jan 2017, 23 (1), 19 (Website: http://www. ethanolproducer.com/) © BBI International 2017.
Synthetic Genomics and ExxonMobil renew algae biofuels research agreement Synthetic Genomics Inc and ExxonMobil announced on 18 Jan 2017 that they have extended their agreement to conduct joint research into advanced algae biofuels after making significant progress in understanding algae genetics, growth characteristics and increasing oil production. ExxonMobil and Synthetic Genomics have been jointly researching and developing oil from algae for use as a renewable, lower-emission alternative to traditional transportation fuels since launching the programme in 2009. Work continues toward developing strains of algae that demonstrate significantly improved photosynthetic efficiency and oil production through selection and genetic engineering of higher-performance algae strains. The agreement continues to focus on Synthetic Genomics' core strengths in synthetic biology and builds on recent discoveries of biological pathways regulating lipid production and growth in advanced algal strains. The vice president for research and development at ExxonMobil Research and Engineering Company, said that renewal of the agreement underscores the importance of the research and recognition of milestones the team has achieved together over the past few years. The development of algae biofuels and a path toward commercial-scale production remain key components of ExxonMobil's suite of research projects focused on producing energy to meet global demand while reducing greenhouse gas emissions to mitigate the risk of climate change.
Original Source: ExxonMobil, 18 Jan 2017, (Website: http://www.exxonmobil.com/) © ExxonMobil Mobil Corporation 2017.
Avantium takes over Liquid Light; commercializing technology for cosmetics production Avantium has announced it has acquired the assets of Liquid Light Inc. Liquid Light has developed proprietary process technology to make major chemicals from low-cost, globallyabundant carbon dioxide (CO2). The acquisition combines the technologies of both Liquid Light and Avantium to develop a world leading electro-catalysis platform and to commercialize new process technologies using CO2 as feedstock to produce sustainable chemicals and materials. Its patent portfolio includes filings on producing multiple chemical building blocks used in large existing markets, including oxalic acid, glycolic acid, ethylene glycol, propylene, isopropanol, methylmethacrylate and acetic acid for the production of polymers, coatings and cosmetics. The technology and patent portfolio of Liquid Light will be integrated in Avantium's Renewable Chemistry business unit and its existing R&D program in electrochemistry. The combination of Liquid Light's expertise in electrochemistry with Avantium's expertise in catalysis and process engineering will be the basis of an unrivalled technology platform to develop novel production technologies for converting CO2 to chemicals and materials.
March 2017